Skip to content

Research and development of full-function vestibular evoked myogenic potential detection equipment

Research and development of full-function vestibular evoked myogenic potential detection equipment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036046
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal healthy people and people with peripheral vestibular dysfunction

Interventions

Gold Standard:A commercially available evoked potential recorder
Index test:full-function&#32
vestibular&#32
myogenic&#32
detection&#32
device

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for normal persons: 1. Healthy young volunteers aged 18 to 50 years old; 2. Chinese citizens; 3. All informed consent. Inclusion criteria for people with vestibular dysfunction: 1. Chinese citizens; 2. patients with peripheral vestibular dysfunction disease as the case group; 3. Under 50 years of age, the diseases include Menieres disease, sudden deafness with vertigo, Acoustic neuroma, vestibular neuritis, auditory neuropathy and otitis media patients were included and screened according to the guidelines; 4. Agree to participate in this study.

Exclusion criteria

Exclusion criteria: Exclusion criteria for normal population: 1. People with a history of deafness, ear disease, ear discharge or vertigo, and other neurological, intracranial, autoimmune and other systemic diseases; 2. Otoscope, audiometery, acoustic immittance test for any abnormality. Exclusion criteria for people with vestibular dysfunction: With non-peripheral vestibular dysfunction disease, accompanied by impaired central vestibular function, intracranial injury, mass, tumor, infarction, Those with multiple systemic diseases or those with central disease in related examinations.

Design outcomes

Primary

MeasureTime frame
p1 latency;n1 latency;threshold;SEN, SPE, ACC, AUC of ROC, Kappa;

Secondary

MeasureTime frame
amplitude;Amplitude asymmetry ratio;

Countries

China

Contacts

Public ContactZhang Qing

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

zhqent@163.com+86 15021607316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026